Chemotherapy and Your Feet: Neuropathy and Protective Care

Quick answer: Chemotherapy Feet Side Effects Neuropathy Protective Care is a common foot/ankle topic that affects many patients. Effective treatment starts with a targeted diagnosis, conservative-first treatment, and escalation only when needed. We treat this regularly at our Howell and Bloomfield Township practices. Call (810) 206-1402.

How Chemotherapy Affects Your Feet

Cancer chemotherapy treats disease by targeting rapidly dividing cells — unfortunately, this mechanism affects not only cancer cells but also the rapidly dividing cells of peripheral nerves, skin, and nails, creating a range of foot side effects that can significantly impact quality of life during and after treatment. Understanding these effects allows patients and oncology teams to take proactive measures that prevent complications and maintain foot function and comfort through the treatment process.

The specific foot problems that develop depend on which chemotherapy agents are used, the cumulative dose, treatment duration, and individual patient susceptibility. Some agents (platinum compounds, taxanes, vinca alkaloids) predominantly cause neuropathy. Others cause skin and nail changes. Some cause multiple effects simultaneously. Patients undergoing treatment should be informed about the foot side effects of their specific regimen so they can monitor their feet and report problems early when they are most treatable.

Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced peripheral neuropathy is the most common and potentially most serious foot complication of cancer treatment. It affects approximately 30-40% of chemotherapy patients and can persist for months to years after treatment completion — sometimes permanently. CIPN occurs because certain chemotherapy drugs damage the peripheral nerves by disrupting microtubules, causing oxidative stress, impairing mitochondrial function, or altering ion channel activity.

The drugs most commonly causing CIPN include platinum compounds (cisplatin, carboplatin, oxaliplatin), taxanes (paclitaxel, docetaxel), vinca alkaloids (vincristine, vinblastine), and bortezomib. CIPN typically begins in a “stocking-glove” distribution — affecting the most distal extremities first, then progressing proximally as treatment continues or cumulative dose increases.

Symptoms of CIPN affecting the feet include numbness, tingling, burning, and shooting or electric pain. Some patients describe feelings of walking on glass, wearing thick socks constantly, or having their feet feel like they belong to someone else. The sensory symptoms are often accompanied by balance disturbance from impaired proprioception, creating fall risk. Motor weakness affecting the feet and ankles can develop in severe cases.

Monitoring for CIPN is essential during chemotherapy. Report any new foot numbness, tingling, or burning to your oncologist promptly — dose reduction or changing agents is sometimes warranted when CIPN becomes significant, as preventing permanent nerve damage is more important than maintaining a specific dose level in many cases. The severity of CIPN often dictates treatment modifications that balance cancer control against quality of life.

Palmar-Plantar Erythrodysesthesia: Hand-Foot Syndrome

Palmar-plantar erythrodysesthesia (PPE), also known as hand-foot syndrome or hand-foot skin reaction, is a specific side effect of certain chemotherapy agents — particularly capecitabine (Xeloda), fluorouracil (5-FU) continuous infusion, and targeted therapies including sorafenib, sunitinib, and other multi-kinase inhibitors. PPE causes redness, swelling, pain, blistering, and peeling of the palms and soles.

The mechanism involves drug accumulation in eccrine sweat gland ducts, particularly in the palms and soles which have the highest sweat gland density. Friction and pressure on these areas worsens the condition — activities that would normally be innocuous (walking, wearing shoes, gripping objects) become painful.

Preventive measures are critical and should begin before symptoms develop. These include wearing padded, well-fitting footwear to reduce friction; avoiding barefoot walking; applying thick emollient creams or petroleum jelly to the soles before activities; soaking feet in cool water; and avoiding excessive heat. Dose modification by the oncologist is the most powerful intervention when symptoms are severe. Topical corticosteroids reduce inflammation and may accelerate symptom resolution.

Nail Changes From Chemotherapy

Chemotherapy-related nail changes affect up to 50% of patients on certain regimens. These include onycholysis (separation of the nail from the nail bed), nail discoloration, Beau’s lines (transverse grooves marking periods of nail plate growth arrest), brittle or fragile nails, and subungual hematomas. Taxane-based regimens (particularly docetaxel) are particularly associated with nail toxicity.

Nail changes are not merely cosmetic — onycholysis creates space under the nail where bacteria and fungi can establish infections, and separated, loose nails are vulnerable to traumatic avulsion. Keeping affected nails clean and dry, using topical antifungals prophylactically, and cutting nails short to reduce use reduces these risks. Dark-colored nail polish during treatment has been studied as a means of reducing nail toxicity, with some positive results from the photoprotective properties of dark pigments.

If nails become significantly separated, infected, or painful, podiatric evaluation can provide appropriate management — including careful removal of loose or infected nail portions and appropriate wound care — without disrupting chemotherapy treatment.

Protecting Your Feet During Cancer Treatment

Several protective foot care strategies apply across multiple chemotherapy regimens. Inspect feet daily for redness, blistering, breaks in skin, nail changes, or any signs of infection. Chemotherapy-related immunosuppression makes infections potentially more serious than in healthy individuals — any wound or infection requires prompt reporting to your oncology team and potentially to a podiatrist.

Wear well-fitting shoes with ample cushioning and soft materials that don’t create friction pressure over vulnerable skin. Avoid barefoot walking even at home. Keep feet clean and moisturized but avoid products with fragrance or potential irritants. Wear moisture-wicking socks and change them if wet. Avoid very hot baths or showers — thermal sensitivity from CIPN makes temperature perception unreliable, increasing burn risk.

At Balance Foot & Ankle, we work with oncology teams to provide specialized foot care for cancer patients undergoing chemotherapy. We understand the unique challenges of foot care in immunocompromised patients, why we not disrupting oncology treatment schedules, and the specific management approaches that minimize foot complications during this difficult time. If you or a family member undergoing chemotherapy has foot concerns, please reach out.

Foot or Ankle Pain? We Can Help.

Balance Foot & Ankle — Howell & Bloomfield Township, MI

📅 Book Online
📞 (810) 206-1402

What is Neuropathy?

Neuropathy is a common foot/ankle condition that affects mobility and quality of life. Understanding the underlying cause is the first step in successful treatment. Our podiatrists at Balance Foot & Ankle perform a hands-on biomechanical exam, review your activity history, and use diagnostic imaging when appropriate to identify the root cause—not just treat the symptom. Many patients have been told to “rest and ice” without a deeper diagnostic workup; our approach is different.

Symptoms and warning signs

Common signs of neuropathy include pain that worsens with activity, morning stiffness, swelling, tenderness when palpated, and difficulty bearing weight. If you experience sudden severe pain, inability to walk, visible deformity, numbness or color change, contact our office the same day or visit urgent care—these can signal a more serious injury such as a fracture, tendon rupture, or vascular compromise. Diabetics with any foot wound should seek same-day care.

Conservative treatment options

Most cases of neuropathy respond to non-surgical care: structured rest, supportive footwear changes, custom orthotics, targeted stretching and strengthening protocols, anti-inflammatory medications when medically appropriate, and in-office procedures such as ultrasound-guided injections. We also offer advanced therapies including laser therapy, EPAT/shockwave, regenerative injections, and image-guided procedures. Treatment is sequenced from least invasive to most invasive, and we explain the rationale at every step.

When is surgery considered?

Surgery is reserved for cases that fail 3-6 months of well-structured conservative care, when there is structural pathology (severe deformity, complete tear, advanced arthritis), or when imaging shows damage that will not heal without intervention. Our surgeons have performed 3,000+ foot and ankle procedures and prioritize minimally-invasive techniques whenever appropriate. We discuss recovery timelines, return-to-activity milestones, and realistic outcome expectations before any procedure is scheduled.

Recovery timeline and prevention

Recovery from neuropathy varies based on severity and chosen treatment path. Conservative cases often improve within 4-8 weeks with consistent adherence to the protocol. Post-procedural recovery may range from a few days (in-office procedures) to several months (reconstructive surgery). Long-term prevention involves footwear assessment, activity modification, structured strengthening, and regular check-ins with your podiatrist if you have a history of recurrence. We provide written home-exercise plans and digital follow-up support.

In-Office Treatment at Balance Foot & Ankle

If home treatment isn’t providing relief for your neuropathy, our podiatry team at Balance Foot & Ankle can help with same-week evaluations and advanced in-office care.

More questions patients ask

How often should diabetics check their feet?

Diabetic patients should perform daily self-examinations of both feet, checking for cuts, blisters, redness, swelling, calluses, and temperature changes. Professional diabetic foot exams should occur at least annually, or every 3-6 months for patients with neuropathy, peripheral artery disease, or history of foot ulcers. Dr. Biernacki provides comprehensive diabetic foot care programs.

Why do diabetics have foot problems?

Diabetes causes peripheral neuropathy (nerve damage reducing sensation), peripheral artery disease (reduced blood flow), and impaired immune function. This combination means injuries go unnoticed, heal slowly, and are prone to infection. Approximately 15% of diabetics will develop a foot ulcer, and diabetic foot complications are the leading cause of non-traumatic amputation. Prevention through regular podiatric care is essential.

What are the signs of diabetic neuropathy in feet?

Early signs include tingling, burning, or numbness starting in the toes and progressing upward. Other symptoms include sensitivity to touch, muscle weakness, balance problems, and loss of reflexes. If you experience any of these symptoms, schedule an evaluation with Dr. Biernacki at 810-206-1402 for nerve conduction testing and a comprehensive neuropathy management plan.

Still have a question about coverage or cost? Book online and we will check your benefits before your visit: Book in Howell · Book in Bloomfield Township. Prefer to talk it through first? Call (810) 206-1402.